Apparent diffusion coefficient restriction in the white matter: going beyond acute brain territorial ischemia

Valentina Citton1, Alberto Burlina, Claudio Baracchini

  • 1University of Padua, Neuroradiological Unit, Padova, Italy, valentina.citton@sanita.padova.it.

Insights Into Imaging
|June 15, 2012
PubMed
Abstract

Insights

Reduced apparent diffusion coefficient (ADC) values in white matter can indicate various conditions beyond ischemia. Recognizing these diverse MRI findings is crucial for accurate diagnosis and appropriate patient management.

Area of Science:

  • Neuroradiology
  • Neuroimaging
  • White Matter Diseases

Background:

  • Reduced apparent diffusion coefficient (ADC) values in white matter are not exclusively indicative of ischemic events.
  • This phenomenon can be associated with a spectrum of non-ischemic neurological conditions.

Purpose of the Study:

  • To identify and characterize diverse neuroradiological findings associated with reduced white matter ADC values.
  • To differentiate these findings from ischemic white matter injury.

Main Methods:

  • Retrospective analysis of MRI records.
  • Focus on centrum semiovale white matter with reduced ADC values, excluding grey matter involvement and significant vasogenic edema.

Main Results:

  • Identified specific MRI patterns for various conditions: X-linked Charcot-Marie-Tooth disease (moose-horn lesions), Menkes disease (fronto-parietal lesions), maple syrup urine disease (neonatal form), glutaric aciduria type 1 (corpus callosum involvement), phenylketonuria (periventricular parieto-occipital abnormalities).
  • Other findings included global cerebral anoxia/heroin inhalation (diffuse abnormalities with necrosis), methotrexate neurotoxicity (reversible fronto-parietal lesions), watershed ischemia (chain-like lesions), reversible splenial lesions, and diffuse axonal injury (splenium involvement).

Conclusions:

  • Familiarity with these varied MRI features is essential for neuroradiologists.
  • Accurate interpretation prevents misdiagnosis and ensures appropriate clinical management of non-ischemic white matter abnormalities.